Skip to content

Public FDA record

Z-2060-2020: Renuvion/ J-Plasma Precise Open Handpiece. Catalog numbers BVX-044-BPS, BVX-044-BPP, BVX-150-BPP, BVX-15

Recall record Z-2060-2020 for Bovie Medical Corporation. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-2060-2020
Company in FDA record
Bovie Medical Corporation
FDA record creation date
May 20, 2020
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

Unexpected stress fractures on the shaft of the hand piece may result in fragmentation during clinical use.

Source facts

Action
On April 23, 2020 Apyx Medical (Formerly Bovie Medical) sent out an URGENT Medical Device Field Safety Notice identifying the problem, under what circumstances it can occur, the actions that should be taken by the customer/user in order to prevent risk to patients/users, and the actions planned by Apyx Medical to correct the problem. PRODUCTS: All lots of the Renuvion/J-Plasma Precise Hand piece with specified Catlog #'s that are not expired, and all lots of the Renuvion/J-Plasma Precise Open Handpiece with specified Catlog #'s that are not expired. ACTIONS TO BE TAKEN BY CUSTOMER/USER: Follow the cleaning instructions provided in the Instructions for Use (IFU) to remove coagulum/eschar from the blade during clinical use: For optimum performance, keep the distal end of the shaft free of debris. A damp gauze pad can be used for cleaning. Do not activate while cleaning the tip. Follow all specified cleaning instructions identified in the Field Safety Notification which are also in the product Instructions for Use (IFU's). Do Not modify or alter the tip of the device. Do Not use a cannula or a skin port that has tight interference with the outer diameter of the shaft of the device. Discontinue using the hand piece if during clinical use if a stress fracture develops and immediately report to Apyx Medical for return if any devices that exhibit this issue during clinical use. Customers should sign and return the customer response form via email indicating they have read and understand the instructions by May 1st of 2020.
Initiated
2020-04-20
Root cause
Under Investigation by firm
Terminated
2022-09-13
Distribution
Worldwide distribution - US nationwide including in the states of Puerto Rico, and the countries of CA, JO, CO, MX, BR, CR, PA, KW, CL, MA, ES, TH, PH, IQ, LB, DO, Japan, QA, AE, PE, AU, VN, IL, Lithuania, UAE, Belgium, Denmark, Austria, Poland, Germany, Slovakia, Spain, Cyprus, Switzerland, Turkey, UK, Italy, Bulgaria, Greece, Norway, Ireland, Hungary, and Croatia.
Recall number
Z-2060-2020
Recall status
Terminated
CDRH record ID
181307
FDA record created
2020-05-20
Recall event number
85597

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗